Recent studies have found that GAB2 was highly expressed in breast cancer, ovarian cancer, lung cancer, glioma and other malignant tumors, and was involved in regulating the occurrence and metastasis of tumors [16–20]. Here, GAB2 is linked to breast carcinoma.